General MedicationsINTRAVENOUSGeneric
CHOLINE C-11
CHOLINE C-11
Standard Dose
4-33.1mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview CHOLINE C-11 is listed in Drugs@FDA under application 208444 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CHOLINE C-11 Form and strength INJECTABLE;INTRAVENOUS - 4-33.1mCi/ML Sponsor UCSF RODIOPHARM Submission history Latest submission status date: 2017-11-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview CHOLINE C-11 is listed in Drugs@FDA under application 208444 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CHOLINE C-11 Form and strength INJECTABLE;INTRAVENOUS - 4-33.1mCi/ML Sponsor UCSF RODIOPHARM Submission history Latest submission status date: 2017-11-20 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.